' Mix and Match' Options Emerging in Automated Insulin Delivery'Mix and Match' Options Emerging in Automated Insulin Delivery
In the pursuit of fully automated"closed-loop" insulin delivery systems, organizations and manufacturers are teaming up to allow for interchangeability among devices.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - June 9, 2019 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Improvements in insulin release wane after treatment stops in adults with type 2 diabetes
(NIH/National Institute of Diabetes and Digestive and Kidney Diseases) A set of clinical trials examining youth and adults with type 2 diabetes or impaired glucose tolerance has found that disease progression in adults slowed during medical treatment but resumed after treatment stopped. Youth on the same treatment had markedly poorer outcomes with continued disease progression both during and after the treatment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 9, 2019 Category: International Medicine & Public Health Source Type: news

Combination medication helps patients with type 2 diabetes maintain blood sugar goals
(Brigham and Women's Hospital) Through a randomized, multicenter clinical trial, investigators studied blood glucose results for patients assigned to either take insulin (insulin glargine, IGlar U100) or insulin degludec plus liraglutide (IDegLira), a combination of both insulin and an additional medication to help with blood sugar control. The global study team found that participants who received IDegLira were better able to achieve blood glucose goals and remain at that goal longer compared to those assigned to receive IGlar. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 9, 2019 Category: International Medicine & Public Health Source Type: news

Abbott device helps in cutting blood sugar in type 2 diabetics: study
Insulin-dependent patients with type 2 diabetes saw a significant drop in their blood sugar levels after wearing Abbott Laboratories Inc's continuous glucose monitoring system for three months compared with those who use routine fingerstick testing, researchers said on Saturday. (Source: Reuters: Health)
Source: Reuters: Health - June 8, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

New Data Show Use of Abbott's FreeStyle ® Libre System Significantly Reduces HbA1c Levels in People Living with Type 2 Diabetes
- Presented as a late-breaker at the American Diabetes Association (ADA) 79th Scientific Sessions, new real-world data demonstrate that monitoring glucose with FreeStyle Libre System has a positive impact among adults with Type 2 Diabetes who use multiple injections of insulin daily (Source: Abbott.com)
Source: Abbott.com - June 8, 2019 Category: Pharmaceuticals Source Type: news

Long-term islet transplant recipients show near-normal glucose control
(Diabetes Research Institute Foundation) Findings from continuous glucose monitoring evaluations in islet transplant recipients who have been insulin independent for an average of 10 years show near normal glycemic profiles and time-in-range metrics, demonstrating that islet transplantation can be a successful long-term therapy for select patients with type 1 diabetes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 8, 2019 Category: International Medicine & Public Health Source Type: news

Diabetic chemist builds biohacked device to treat the disease
Dr Orla Wilson spent some 30 years checking her blood sugar levels and giving herself shots or pump-pushes of insulin. Then she built a device that automates the process for her and her daughter. (Source: the Mail online | Health)
Source: the Mail online | Health - June 8, 2019 Category: Consumer Health News Source Type: news

Avoid Fingersticks for Diabetes Dosing Decisions With Eversense Avoid Fingersticks for Diabetes Dosing Decisions With Eversense
Eversense, Senseonics'long-term implantable continuous glucose monitor, can now be used"nonadjunctively" so that patients don't need to do fingersticks for insulin dosing decisions.FDA Approvals (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - June 7, 2019 Category: Endocrinology Tags: Diabetes & Endocrinology News Alert Source Type: news

Chronic synaptic insulin resistance after traumatic brain injury abolishes insulin protection from amyloid beta and tau oligomer-induced synaptic dysfunction - Franklin W, Krishnan B, Taglialatela G.
Traumatic brain injury (TBI) is a risk factor for Alzheimer's disease (AD), although the mechanisms contributing to this increased risk are unknown. Insulin resistance is an additional risk factor for AD whereby decreased insulin signaling increases synapt... (Source: SafetyLit)
Source: SafetyLit - June 6, 2019 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Tea bag of insulin cells could beat diabetes by controlling blood sugar
Scientists at Manchester University made the device, which is about the size of a 5p piece, is implanted next to the liver. (Source: the Mail online | Health)
Source: the Mail online | Health - June 4, 2019 Category: Consumer Health News Source Type: news

Plastics Joining —Do You Know Your Options?
Product designers and manufacturers face constant challenges in developing and cost effectively producing high-quality medical equipment and devices for everything from monitoring to drug-delivery, to daily care, wound care, surgical, and therapeutic uses. Often, my work supports their manufacturing operations by helping them bring new product designs to market. It often begins with evaluating concepts and ideas—often in prototype form—to help manufacturers select and implement an assembly/joining process that meets product performance, quality, cleanliness, and cost goals. Though some j...
Source: MDDI - June 4, 2019 Category: Medical Devices Authors: Matt Jones Tags: Materials Source Type: news

Type 2 diabetes: The one major fast fix to reverse the condition
TYPE 2 diabetes is a condition in which cells cannot use blood sugar effectively for energy. It occurs when blood sugar gets too high and over time the cells become insensitive to insulin. Can the condition be reversed? (Source: Daily Express - Health)
Source: Daily Express - Health - June 1, 2019 Category: Consumer Health News Source Type: news

US Drug Prices Rise in'Highly Synchronized' Pattern US Drug Prices Rise in'Highly Synchronized' Pattern
A new study reports"highly synchronized" changes in the prices of competing drugs, including widely used forms of insulin.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - June 1, 2019 Category: Endocrinology Tags: Family Medicine/Primary Care News Source Type: news

The Week That Wasn't: Stroke Bacteria, Linoleic Acid, $100 Insulin Cap The Week That Wasn't: Stroke Bacteria, Linoleic Acid, $100 Insulin Cap
A quick overview of three medical stories that are worth a mention.Medscape (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - May 31, 2019 Category: Internal Medicine Tags: Family Medicine/Primary Care Article Source Type: news

Medical News Today: What to know about insulin and weight gain
This article looks at the link between diabetes, insulin, and gaining weight. It also describes how to manage or prevent this potential effect. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 31, 2019 Category: Consumer Health News Tags: Diabetes Source Type: news

How the Microbiome Might Predict Diabetes, Premature Birth and Gut Diseases
Over the last 10 years, the U.S. National Institutes of Health has invested $170 million to better understand the universe of bacteria that live within us—the so-called microbiome. In the first phase of the project, researchers focused on cataloguing the myriad types of microbes found throughout the body, including in the mouth, nose, gut, and reproductive tract. The latest phase of the research, described in three papers published May 29 in Nature and Nature Medicine, focused on better understanding how changes in those microbial populations affect three conditions: diabetes, preterm birth and inflammatory bowel dis...
Source: TIME: Health - May 30, 2019 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized diabetes gut microbes microbiome Reproductive Health Research Source Type: news

Type 2 diabetes: Does your skin feel like this? Unusual symptom to look out for
TYPE 2 diabetes is a condition in which cells cannot use blood sugar efficiently for energy. This occurs when blood sugar levels get too high over time and the cells become resistant to insulin. A condition on your skin is a major sign of type 2 diabetes. Do you have this skin infection? (Source: Daily Express - Health)
Source: Daily Express - Health - May 30, 2019 Category: Consumer Health News Source Type: news

High-fat meals increase triglycerides and lower HDL cholesterol in obese, insulin-resistant individuals
(Natural News) A study published in the journal Nutrition Research looked at the association between postprandial insulin resistance and lipid metabolism in abdominally obese individuals. The study was conducted by researchers from Southeast University and Ningxia Medical University in China. Abdominal obesity is associated with an increased risk of insulin resistance, which may contribute to abnormal... (Source: NaturalNews.com)
Source: NaturalNews.com - May 28, 2019 Category: Consumer Health News Source Type: news

$800 million spin-out deal wins global award for University ’ s Research Commercialisation Team
The sale of a University of Bristol spin-out company working on technology to develop next-generation insulin has won a global award. (Source: University of Bristol news)
Source: University of Bristol news - May 28, 2019 Category: Universities & Medical Training Tags: Business and Enterprise, Announcements, Staff notices; Faculty of Science; Press Release Source Type: news

Antibiotic use linked to increased risk of heart attack and stroke in women
Risk is greatest for older women who take antibiotics for more than two months Related items fromOnMedica Withdrawn valsartan meds not linked to short-term cancer risk Cardio risk raised in people using long-acting bronchodilators Recurrent stroke more likely at very low BP Rising use of antithrombotics linked to subdural haematoma Adding insulin to metformin linked to higher mortality (Source: OnMedica Latest News)
Source: OnMedica Latest News - May 28, 2019 Category: UK Health Source Type: news

The price of insulin is surging. This state is the first to make insurance companies eat the cost.
The Colorado law will cap monthly co-payments at $100, but doesn't change how much insulin manufacturers can charge. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - May 24, 2019 Category: Consumer Health News Authors: Orion Donovan-Smith Source Type: news

Colorado first state to cap soaring insulin prices
Drug's price has doubled in five years, so state is capping co-payments for diabetics with private insurance at $100 a month (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - May 24, 2019 Category: Consumer Health News Source Type: news

Colorado is the first state to cap skyrocketing insulin co-pays
The skyrocketing prices of insulin are a nationwide issue and Colorado has become the first state to pass legislation that tackles the problem. (Source: CNN.com - Health)
Source: CNN.com - Health - May 23, 2019 Category: Consumer Health News Source Type: news

Half-Price Version of Humalog Insulin Available
The company's generic version of its Humalog U-100 is being sold under the chemical name insulin lispro, (Source: WebMD Health)
Source: WebMD Health - May 23, 2019 Category: Consumer Health News Source Type: news

Short duration, high-intensity resistance exercise training programs can dramatically improve insulin sensitivity in overweight men: Study
(Natural News) People who are overweight are often advised to exercise to lose weight. Now, a study finds that this not only aids in weight loss but also in improving insulin sensitivity. The paper, published in the journal Experimental Physiology, suggests a six-week short duration, high-intensity exercise training program to significantly improve insulin sensitivity, as well as muscle size... (Source: NaturalNews.com)
Source: NaturalNews.com - May 23, 2019 Category: Consumer Health News Source Type: news

Half-Price Version of Humalog Insulin Now Available
Title: Half-Price Version of Humalog Insulin Now AvailableCategory: Health NewsCreated: 5/22/2019 12:00:00 AMLast Editorial Review: 5/23/2019 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - May 23, 2019 Category: Endocrinology Source Type: news

How insulin prices got out of control and what's being done about it
Insulin prices have skyrocketed, especially in the past 20 years. Is any financial relief on the way for the millions of patients that need insulin to live? (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 23, 2019 Category: American Health Authors: Alisha Green Source Type: news

How insulin prices got out of control and what's being done about it
Insulin prices have skyrocketed, especially in the past 20 years. Is any financial relief on the way for the millions of patients that need insulin to live? (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 23, 2019 Category: Biotechnology Authors: Alisha Green Source Type: news

Large trial says aspirin safe for brain bleed stroke patients
Study says brain haemorrhage survivors should continue taking antiplatelet medicines Related items fromOnMedica Treatment of hypertension for low-risk patients questioned Avoid BP-lowering drugs in stroke Adding insulin to metformin linked to higher mortality Stroke rate higher in HIV patients Risk/benefit balance of alteplase shifts quickly (Source: OnMedica Latest News)
Source: OnMedica Latest News - May 23, 2019 Category: UK Health Source Type: news

Eli Lilly's lower-priced insulin goes on sale amid drug price debate
A cheaper generic version of the rapid-acting insulin Humalog has hit the market, according to a statement Wednesday by drugmaker Eli Lilly. (Source: CNN.com - Health)
Source: CNN.com - Health - May 22, 2019 Category: Consumer Health News Source Type: news

Half-Price Version of Humalog Insulin Now Available
WEDNESDAY, May 22, 2019 -- A half-price version of Humalog insulin is now available in the United States, Eli Lilly said Wednesday. The company's generic version of its Humalog U-100 is being sold under the chemical name insulin lispro, the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 22, 2019 Category: Pharmaceuticals Source Type: news

UNC researchers develop smarter "I-insulin"
Research coming out of UNC Chapel Hill has the potential to create a "smart insulin" that could reduce diabetic patient completions and significantly change how patients manage their condition. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 22, 2019 Category: Biotechnology Authors: Seth Thomas Gulledge Source Type: news

UNC researchers develop smarter "I-insulin"
Research coming out of UNC Chapel Hill has the potential to create a "smart insulin" that could reduce diabetic patient completions and significantly change how patients manage their condition. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 22, 2019 Category: American Health Authors: Seth Thomas Gulledge Source Type: news

Manage obesity complications with this South American plant
(Natural News) Obesity isn’t just about the number on the weighing scale. In fact, this condition leads to various health complications, causing inflammation that contributes to the development of insulin resistance, glucose intolerance, and liver damage. Scientists have explored many natural cures for obesity and its complications. One of these is a South American plant called Rudgea viburnoides.... (Source: NaturalNews.com)
Source: NaturalNews.com - May 22, 2019 Category: Consumer Health News Source Type: news

Seeking to save billions of dollars, employers turn to Bay Area companies to help with diabetes
For diabetic workers, access to a refrigerator and insulin breaks are not a workplace perk. They are potentially a matter of life and death. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - May 22, 2019 Category: Health Management Authors: Hannah Norman Source Type: news

What ’s the Latest in Drug-Delivery Devices?
To simplify drug delivery for patients and practitioners, drug-delivery devices are becoming more complex. Many of today’s devices include special features designed to ease self-dosing and encourage patient adherence with novel regimens. Wearable devices are further easing use by promoting active lifestyles. And some devices are offering connectivity to support digital health monitoring. With so many possibilities, where do device developers and pharmaceutical companies begin? MD+DI asked Eric Resnick, vice president and chief technology officer, innovation and technology, West Pharmaceutical Services Inc...
Source: MDDI - May 22, 2019 Category: Medical Devices Authors: Daphne Allen Tags: Packaging Source Type: news

UNC researchers develop smarter "I-insulin"
Research coming out of UNC Chapel Hill has the potential to create a "smart insulin" that could reduce diabetic patient completions and significantly change how patients manage their condition. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - May 22, 2019 Category: Health Management Authors: Seth Thomas Gulledge Source Type: news

Eli Lilly's half-price insulin goes on sale, but critics say it's still too costly
Eli Lilly's lower-cost version of its Humalog insulin still costs much more than insulin sold outside the U.S. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - May 22, 2019 Category: Consumer Health News Source Type: news

900-lb. Man Pleads in Drug Case from Ambulance
RICHMOND, Va. (AP) — A Virginia man who weighs more than 900 pounds (410 kilograms) pleaded guilty in a federal cocaine conspiracy case Tuesday during a hearing that was held in a courthouse loading dock as the defendant lay on a stretcher inside an ambulance. U.S. Magistrate Judge David Novak said the court engaged in "some extraordinary procedures" Tuesday to deal with Kenneth Hicks' health issues and to "protect his dignity." Hicks, 48, stayed inside the ambulance and wasn't visible to several of his family members and reporters who attended the hearing. He was visible to Novak and a prosecutor...
Source: JEMS: Journal of Emergency Medical Services News - May 22, 2019 Category: Emergency Medicine Tags: Rescue & Vehicle Extrication News Operations Source Type: news

900-lb. Man Pleads in Drug Case from Ambulance
RICHMOND, Va. (AP) — A Virginia man who weighs more than 900 pounds (410 kilograms) pleaded guilty in a federal cocaine conspiracy case Tuesday during a hearing that was held in a courthouse loading dock as the defendant lay on a stretcher inside an ambulance. U.S. Magistrate Judge David Novak said the court engaged in "some extraordinary procedures" Tuesday to deal with Kenneth Hicks' health issues and to "protect his dignity." Hicks, 48, stayed inside the ambulance and wasn't visible to several of his family members and reporters who attended the hearing. He was visible to Novak and a prosecutor...
Source: JEMS Operations - May 22, 2019 Category: Emergency Medicine Tags: Rescue & Vehicle Extrication News Operations Source Type: news

Lilly selling half-price version of popular Humalog insulin
A half-price version of Eli Lilly's popular Humalog insulin is now available under the name Insulin Lispro, after the drugmaker promised a more affordable option amid soaring insulin prices. (Source: ABC News: Health)
Source: ABC News: Health - May 22, 2019 Category: Consumer Health News Tags: Health Source Type: news

Medical News Today: How fasting may prevent obesity-related insulin resistance
Scientists conducted a small study of the 30-day fasting practice of Ramadan and found evidence of significant metabolic benefits. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 22, 2019 Category: Consumer Health News Tags: Obesity / Weight Loss / Fitness Source Type: news

Seeking to save billions of dollars, employers turn to Bay Area companies to help with diabetes
For diabetic workers, access to a refrigerator and insulin breaks are not a workplace perk. They are potentially a matter of life and death. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 22, 2019 Category: Pharmaceuticals Authors: Hannah Norman Source Type: news

Seeking to save billions of dollars, employers turn to Bay Area companies to help with diabetes
For diabetic workers, access to a refrigerator and insulin breaks are not a workplace perk. They are potentially a matter of life and death. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 22, 2019 Category: Biotechnology Authors: Hannah Norman Source Type: news

Verily Forms ‘Ultimate Alliance’ with Pharma Heavy Hitters
What is Alphabet’s Verily up to now, is probably a question that is asked and answered on a regular basis. Google’s farmer life science’s arm has worked with some pretty big players in healthcare on projects ranging from surgical robotics to smart contact lenses. On Tuesday, Verily revealed yet another long-term project – one that would have it work with some of the top players in the pharmaceutical industry, in an effort to improve clinical research. The company said it had formed strategic alliances with Novartis, Otsuka, Pfizer, and Sanofi to implem...
Source: MDDI - May 22, 2019 Category: Medical Devices Authors: Omar Ford Tags: Digital Health Business Source Type: news

ME & MY OPERATION: The ‘Smart’ pump that could mean end of type 1 diabetes jabs
In a breakthrough for type 1 diabetes, a new insulin pump could help millions. Alice Beagley, 25, an events organiser in London, was given the device to try... (Source: the Mail online | Health)
Source: the Mail online | Health - May 20, 2019 Category: Consumer Health News Source Type: news

FDA Slams the Use of Unauthorized Diabetes Management Devices
FDA is hoping to put the brakes on the use of unapproved or unauthorized devices for diabetes management. The federal agency is putting out a stern warning that the use of these unauthorized technologies could result in inaccurate blood glucose measurements or unsafe insulin dosing. This in turn could lead to injury requiring medical intervention or even death. In a release, the agency said it is aware that patients may choose to create these systems or purchase unauthorized or unapproved components or systems because of personal preference or for cost reasons. FDA said it is concerned that patients may not fully be aware ...
Source: MDDI - May 20, 2019 Category: Medical Devices Authors: Omar Ford Tags: Regulatory and Compliance Source Type: news

Converting Analogue to Human Insulin: A Step-by-Step Guide Converting Analogue to Human Insulin: A Step-by-Step Guide
Drs Jay Shubrook and Anne Peters walk through the steps necessary to successfully convert a patient from analogue to human insulin.Medscape Family Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 20, 2019 Category: Consumer Health News Tags: Family Medicine/Primary Care Expert Interview Source Type: news

Discovery in mice could remove roadblock to more insulin production
(Michigan Medicine - University of Michigan) A new discovery made mainly in mice could provide new options for getting the insulin-making 'factories' of the pancreas going again when diabetes and obesity have slowed them down. It could offer new pathways to ramping up insulin supply to get metabolism back on track in people with Type 1 and Type 2 diabetes, and obesity. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 20, 2019 Category: Biology Source Type: news